These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2134208

  • 1. Immunoglobulin subclasses in the urine of control and streptozotocin-induced diabetic rats and their role in the development of diabetic nephropathy.
    McDonald TL, Thiele GM.
    Diabetes Res; 1990 Apr; 13(4):169-76. PubMed ID: 2134208
    [Abstract] [Full Text] [Related]

  • 2. Assessment of the role of the immunoglobulin isotypes in the development of diabetic nephropathy in untreated streptozotocin-induced diabetic rats.
    Thiele GM, McDonald TL.
    Diabetes Res; 1989 Sep; 12(1):15-24. PubMed ID: 2698301
    [Abstract] [Full Text] [Related]

  • 3. Immunoglobulin isotypes in the circulating immune complexes of diabetic rats with and without proteinuria: a chronological study.
    Thiele GM, McDonald TL.
    J Clin Lab Immunol; 1987 Jan; 22(1):19-28. PubMed ID: 3104596
    [Abstract] [Full Text] [Related]

  • 4. [Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy].
    Yashima I, Hirayama T, Shiiki H, Kanauchi M, Dohi K.
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):787-96. PubMed ID: 10655727
    [Abstract] [Full Text] [Related]

  • 5. Urinary IgG4: an additional parameter in characterizing patients with incipient diabetic nephropathy.
    Gambardella S, Morano S, Cancelli A, Pietravalle P, Frontoni S, Bacci S, Di Mario U, Andreani D.
    Diabetes Res; 1989 Apr; 10(4):153-7. PubMed ID: 2612110
    [Abstract] [Full Text] [Related]

  • 6. Protective role of renal nerves in the development of diabetic nephropathy.
    Matsuoka H.
    Diabetes Res; 1993 Apr; 23(1):19-29. PubMed ID: 7924145
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the presence of circulating immune complexes and their relationship to glomerular IgG deposits in streptozotocin-induced diabetic rats.
    Abrass CK.
    Clin Exp Immunol; 1984 Jul; 57(1):17-24. PubMed ID: 6378460
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats.
    Komers R, Lindsley JN, Oyama TT, Anderson S.
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(1-2):36-41. PubMed ID: 17201733
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of varied protein intake on the nephropathy of the diabetic mouse (C57BL/s J db/db).
    Brouhard BH, Rajaraman S, LaGrone LF.
    Int J Pediatr Nephrol; 1987 Jul; 8(2):59-68. PubMed ID: 3308729
    [Abstract] [Full Text] [Related]

  • 12. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW, Kim HJ, Bae JS, Jeong GH, Chung SC, Kim JG, Park SH, Kim YL, Kam S, Kim IS, Kim BW.
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
    D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H.
    Auton Neurosci; 2003 Mar 28; 104(2):88-94. PubMed ID: 12648610
    [Abstract] [Full Text] [Related]

  • 15. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes.
    D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H.
    Horm Metab Res; 2001 Nov 28; 33(11):664-9. PubMed ID: 11733869
    [Abstract] [Full Text] [Related]

  • 16. Increased urinary IgG/albumin index in normoalbuminuric insulin-dependent diabetic patients: a laboratory artefact.
    Hoogenberg K, Visser P, Marrink J, Sluiter WJ, Dullaart RP.
    Diabet Med; 1996 Jul 28; 13(7):651-5. PubMed ID: 8840100
    [Abstract] [Full Text] [Related]

  • 17. High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy.
    Sugano M, Yamato H, Hayashi T, Ochiai H, Kakuchi J, Goto S, Nishijima F, Iino N, Kazama JJ, Takeuchi T, Mokuda O, Ishikawa T, Okazaki R.
    Nutr Metab Cardiovasc Dis; 2006 Oct 28; 16(7):477-84. PubMed ID: 17015185
    [Abstract] [Full Text] [Related]

  • 18. Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor.
    Whitty MR, Jackson B.
    Diabetes Res; 1988 Jun 28; 8(2):91-6. PubMed ID: 2852570
    [Abstract] [Full Text] [Related]

  • 19. Early urinary and plasma biomarkers for experimental diabetic nephropathy.
    Alter ML, Kretschmer A, Von Websky K, Tsuprykov O, Reichetzeder C, Simon A, Stasch JP, Hocher B.
    Clin Lab; 2012 Jun 28; 58(7-8):659-71. PubMed ID: 22997966
    [Abstract] [Full Text] [Related]

  • 20. Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia.
    Viberti GC, Mackintosh D, Bilous RW, Pickup JC, Keen H.
    Kidney Int; 1982 May 28; 21(5):714-20. PubMed ID: 7050509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.